Skye Bioscience, Inc. (SKYE) stock

SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30

$1.08+0.16 (+17.52%)

Close on Nov 12, 2026Market cap $38.26MP/E –Yield –

Skye Bioscience statistics

62 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $38.26M; $280.48M
Enterprise Value: $28.19M; $148.62M

Share statisticsIndustry

Shares Outstanding: 35M; 58M
Shares Change (YoY): 0.38%; 10.9%
Shares Change (QoQ): 0.05%; 0.51%
Shares Held by Institutions: 5.65%; 56.4%

Short sellingIndustry

Short Interest: 129,314; –
Short Interest Change: -7.84%; -0.76%
Short % of Shares Outstanding: 0.37%; 6.30%
Days to Cover: 6.28; 5.13

Stock price statisticsIndustry

52-Week High: $12.72; –
52-Week Low: $0.50; –
20-Day Moving Average: $1.29; –
50-Day Moving Average: $1.57; –
200-Day Moving Average: $4.54; –
Average True Range (14): $0.20; –
Price Change (1 Week): 3.85%; 1.51%
Price Change (1 Month): -31.2%; -2.35%
Price Change (3 Months): -73.1%; -21.1%
Price Change (6 Months): -84.5%; -22.6%
Price Change (YTD): -82.0%; -22.6%
Price Change (1 Year): -90.8%; -20.7%
Price Change (3 Years): -92.1%; -27.4%
Price Change (5 Years): -99.2%; -77.3%
Price Change (10 Years): -99.9%; -62.7%
Average Volume (10 Days): 217,482; –
Average Volume (20 Days): 118,122; –
Average Volume (90 Days): 91,630; –
Relative Volume: 1.79; 0.79
Relative Strength Index (14): 40.1; 44.7
Volatility (1 Year): 100.5%; 80.4%
Beta (5 Years): 1.48; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -233.9%; -51.2%
Return on Assets (ROA): -159.8%; -40.6%

Financial positionIndustry

Current Ratio: 0.95; 3.30
Quick Ratio: 0.87; 2.42
Interest Coverage: -9439.02; -6.35

EfficiencyIndustry

Profits Per Employee: -$4.21M; -$683.67K
Employee Count: 12; 75
WACC: 12.4%; 10.1%

Income statement (TTM)Industry

Operating Income: -$51.90M; -$20.99M
Pretax Income: -$50.49M; -$13.23M
Net Income: -$50.49M; -$21.61M
EBITDA: -$51.21M; -$16.85M
EPS (Diluted): -$1.27; -$0.75

Balance sheetIndustry

Cash & Short-Term Investments: $10.06M; $67.63M
Net Cash (Debt): $10.06M; $17.46M
Net Cash Per Share: $0.28; $0.72
Equity (Book Value): -$497.31K; $53.27M
Book Value Per Share: -$0.01; $1.50
Tangible Book Value: -$497.31K; $26.82M
Working Capital: -$572.22K; $79.47M

Cash flow (TTM)Industry

Operating Cash Flow: -$38.81M; -$12.27M
Capital Expenditures: $0; -$944.00K
Free Cash Flow: -$38.81M; -$18.20M
FCF Per Share: -$1.10; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -132.0%; -20.8%
FCF Yield: -101.5%; -9.58%

Taxes and interestIndustry

Interest Expense: $5.50K; $2.93M
Income Tax: $3.40K; $74.00K

Scores and fair valueIndustry

Altman Z-Score: -40.26; 0.30
Piotroski F-Score: 1; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	SKYE	S&P 500	Difference	SKYE per year	S&P 500 per year
1 month	-31.6%	-2.7%	−28.9 pts
3 months	-75.4%	-1.7%	−73.7 pts
Year to date	-82.0%	+11.9%	−93.9 pts
1 year	-91.1%	+12.0%	−103.1 pts
3 years	-92.1%	+78.2%	−170.2 pts	-57.0%	+21.2%
5 years	-99.2%	+73.2%	−172.4 pts	-61.9%	+11.6%
10 years	-99.9%	+309.6%	−409.5 pts	-48.7%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M SKYE shares were sold short on Oct 30, 2026, down 7.8% from the previous report. At recent volumes it would take 6.3 days to buy them back. Over the last 20 sessions, 25.5% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	129,314	-7.8%	20,583	6.3
Oct 15, 2026	140,313	-5.2%	28,640	4.9
Sep 30, 2026	147,954	+26.4%	85,208	1.7
Sep 15, 2026	117,086	-9.1%	86,091	1.4
Aug 31, 2026	128,781	-89.3%	217,817	1.0
Aug 14, 2026	1,203,600	-8.6%	799,341	1.5
Jul 31, 2026	1,316,797	+24.9%	104,833	12.6
Jul 15, 2026	1,054,357	+10.9%	132,231	8.0
Jun 30, 2026	950,654	-2.5%	133,002	7.2
Jun 15, 2026	974,765	-13.5%	202,290	4.8
May 29, 2026	1,126,334	-11.2%	170,323	6.6
May 15, 2026	1,268,178	-1.3%	175,331	7.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?